Back to Treatments

Treatment

Vincristine + 5-Fluorouracil (5-FU)

1

Conditions

5

Trials

3,000

Participants

30%

Average Safety

Condition Evidence

Hepatoblastoma

5 trials · 3,000 participants

60% effectiveness · 30% safety

Vincristine + 5-Fluorouracil (5-FU) | DFDA